Scott Baum
- Internal Medicine top 5%
- Emergency Medicine top 10%
- Trauma and Emergency Care Studies 2
-
- Renal and Vascular Pathologies 2
-
- Virus-based gene therapy research 3
-
- Cancer Research and Treatments 2
-
- Cancer Immunotherapy and Biomarkers 2
-
- Immunotherapy and Immune Responses 2
-
- Cancer Genomics and Diagnostics 2
-
- Radiopharmaceutical Chemistry and Applications 1
- Co-authors
- EUGENE C. MANGIANTETimothy C. FabianKenneth A. KudskR. E. GoldGuy VoellerIna L.D. TonkinThomas F. BouldenMartin A. Croce
- Journals
- Journal of Clinical Oncology (3 papers)CardioVascular and Interventional Radiology (2 papers)Annals of Oncology (1 paper)
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
Scott Baum
16 papers receiving 317 citations
Peers
Comparison fields: 5 of 44
- Internal Medicine 108
- Emergency Medicine 74
- Pulmonary and Respiratory Medicine 125
- Critical Care and Intensive Care Medicine 19
- Genetics 39
Countries citing papers authored by Scott Baum
This map shows the geographic impact of Scott Baum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Baum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Baum more than expected).
Fields of papers citing papers by Scott Baum
This network shows the impact of papers produced by Scott Baum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Baum. The network helps show where Scott Baum may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Scott Baum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 0 | |
| 2 | 2021 | 1 | |
| 3 | 2021 | 2 | |
| 4 | 2020 | 16 | |
| 5 | Initial results of the phase 1 portion of an ongoing phase 1/2 study of RP1 as a single agent and in combination with nivolumab in patients with solid tumors | 2019 | 1 |
| 6 | 2019 | 3 | |
| 7 | 2018 | 8 | |
| 8 | 2017 | 1 | |
| 9 | 2016 | 15 | |
| 10 | Role of Genomic Instability in Immunotherapy with Checkpoint Inhibitors. | 2016 | 26 |
| 11 | 1992 | 24 | |
| 12 | 1991 | 48 | |
| 13 | 1991 | 4 | |
| 14 | 1991 | 50 | |
| 15 | 1990 | 2 | |
| 16 | 1989 | 124 | |
| 17 | Angiography in the diagnosis and treatment of nonvariceal bleeding in patients with portal hypertension. | 1974 | 2 |
About Scott Baum
Scott Baum is a scholar working on Transplantation, Internal Medicine and Biotechnology, having authored 17 papers that have together received 327 indexed citations. Recurring topics across this work include Virus-based gene therapy research (3 papers), Cancer Research and Treatments (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Immunotherapy and Immune Responses (2 papers), Renal and Vascular Pathologies (2 papers), Cancer Genomics and Diagnostics (2 papers), Trauma and Emergency Care Studies (2 papers) and Radiopharmaceutical Chemistry and Applications (1 paper). The work is most often cited by research in Internal Medicine (108 citations), Emergency Medicine (74 citations) and Pulmonary and Respiratory Medicine (125 citations). Scott Baum has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include EUGENE C. MANGIANTE, Timothy C. Fabian, Kenneth A. Kudsk, R. E. Gold, Guy Voeller, Ina L.D. Tonkin, Thomas F. Boulden, Martin A. Croce, L Britt and Morris L. Gavant. Their work appears in journals such as Journal of Clinical Oncology, CardioVascular and Interventional Radiology, Annals of Oncology, Journal of Digital Imaging and The American Journal of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.